Peteris Darzins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peteris Darzins has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Laura Fanning
Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
3 shared publications - Ian Chi Kei Wong
The University of Hong Kong
2 shared publications - Kevin Mc Namara
Deakin Rural Health, School of Medicine, Deakin University, Warrnambool, Australia
2 shared publications - Raphael Hau
Monash University
2 shared publications - Shawn Marshall
Bruyere Research Institute, Ottawa, ON, Canada
2 shared publications - Sjaan Koppel
Monash University Accident Research Centre, Monash University
2 shared publications
Latest Publications
- Open Access
- 1 September 2020
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 6 (3) , 139-145
Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function
- 1 September 2020
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 6 (3) , 139-145
Open AccessSarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function
- 1 August 2020
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 21 (8) , 1058-1064.e6
Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia
- 1 August 2020
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 21 (8) , 1058-1064.e6
Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia
- 13 May 2019
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 42 (26) , 3825-3832
Direct supervision of physiotherapists improves compliance with clinical practice guidelines for patients with hip fracture: a controlled before-and-after study
Purpose: To determine if the addition of direct supervision to usual clinical supervision practice of physiotherapists can improve compliance with clinical practice guidelines and post-surgical outcomes for inpatients with hip fracture. Methods: A controlled before-and-after study was conducted on two acute orthopedic wards. Junior and mid-level physiotherapists on one ward were provided with direct supervision during their post-operative management of patients with hip fracture. Physiotherapists on the comparison ward received usual reflective supervision. The primary outcome was patient compliance with the hip fracture guideline to mobilize on the day following surgery. Secondary patient outcomes included physical function on the fifth post-operative day. Results: Data were collected from 290 patients with acute hip fracture. Patients at the direct supervision site were more likely to mobilize on the day after surgery [OR 3.14, 95% confidence interval (CI) 1.41–7.01; p = 0.005] and by the second post-operative day (OR 4.62, 95% CI 2.31–9.23; p < 0.001) compared to patients at the comparison site. Patients walked further on the fifth post-operative day (p < 0.001) with less assistance from therapists (p = 0.044). Conclusions: The addition of direct supervision improved physiotherapists’ compliance with hip fracture guidelines and walking endurance and independence in hospitalized patients with hip fracture.
- 13 May 2019
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 42 (26) , 3825-3832
Direct supervision of physiotherapists improves compliance with clinical practice guidelines for patients with hip fracture: a controlled before-and-after study
Purpose: To determine if the addition of direct supervision to usual clinical supervision practice of physiotherapists can improve compliance with clinical practice guidelines and post-surgical outcomes for inpatients with hip fracture. Methods: A controlled before-and-after study was conducted on two acute orthopedic wards. Junior and mid-level physiotherapists on one ward were provided with direct supervision during their post-operative management of patients with hip fracture. Physiotherapists on the comparison ward received usual reflective supervision. The primary outcome was patient compliance with the hip fracture guideline to mobilize on the day following surgery. Secondary patient outcomes included physical function on the fifth post-operative day. Results: Data were collected from 290 patients with acute hip fracture. Patients at the direct supervision site were more likely to mobilize on the day after surgery [OR 3.14, 95% confidence interval (CI) 1.41–7.01; p = 0.005] and by the second post-operative day (OR 4.62, 95% CI 2.31–9.23; p < 0.001) compared to patients at the comparison site. Patients walked further on the fifth post-operative day (p < 0.001) with less assistance from therapists (p = 0.044). Conclusions: The addition of direct supervision improved physiotherapists’ compliance with hip fracture guidelines and walking endurance and independence in hospitalized patients with hip fracture.
- Open Access
- 20 July 2018
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 65 (2) , 489-517
Prevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis
Background: Differences in management and outcomes of oral anticoagulant (OAC) use may exist for people with and without dementia or cognitive impairment (CI). Objective: To systematically review the prevalence and safety and effectiveness outcomes of OAC use in people with and without dementia or CI. Methods: MEDLINE, EMBASE, and CINAHL were searched for studies reporting prevalence or safety and effectiveness outcomes of OAC use for people with and without dementia, published between 2000 to September 2017. Study selection, data extraction, and quality assessment were performed by two reviewers. Results: studies met pre-specified inclusion criteria (21 prevalence studies, 6 outcomes studies). People with dementia had 52% lower odds of receiving OAC compared to people without dementia. Mean OAC prevalence was 32% for people with dementia, compared to 48% without dementia. There was no difference in the composite outcome of embolic events, myocardial infarction, and all-cause death between dementia and non-dementia groups (adjusted hazard ratio (HR) 0.72, 95% CI, 0.45–1.14, p = 0.155). Bleeding rate was lower for people without dementia (HR 0.56, 95% CI, 0.37–0.85). Adverse warfarin events were more common for residents of long-term care with dementia (adjusted incidence rate ratio 1.48, 95% CI, 1.20–1.82). Community-dwelling people with dementia treated with warfarin had poorer anticoagulation control than those without dementia (mean time in therapeutic range (TTR) % ±SD, 38±26 (dementia), 61±27 (no dementia), p < 0.0001). Conclusion: A lower proportion of people with dementia received oral anticoagulation compared with people without dementia. People with dementia had higher bleeding risk and poorer anticoagulation control when treated with warfarin.
- 20 July 2018
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 65 (2) , 489-517
Open AccessPrevalence, Safety, and Effectiveness of Oral Anticoagulant Use in People with and without Dementia or Cognitive Impairment: A Systematic Review and Meta-Analysis
Background: Differences in management and outcomes of oral anticoagulant (OAC) use may exist for people with and without dementia or cognitive impairment (CI). Objective: To systematically review the prevalence and safety and effectiveness outcomes of OAC use in people with and without dementia or CI. Methods: MEDLINE, EMBASE, and CINAHL were searched for studies reporting prevalence or safety and effectiveness outcomes of OAC use for people with and without dementia, published between 2000 to September 2017. Study selection, data extraction, and quality assessment were performed by two reviewers. Results: studies met pre-specified inclusion criteria (21 prevalence studies, 6 outcomes studies). People with dementia had 52% lower odds of receiving OAC compared to people without dementia. Mean OAC prevalence was 32% for people with dementia, compared to 48% without dementia. There was no difference in the composite outcome of embolic events, myocardial infarction, and all-cause death between dementia and non-dementia groups (adjusted hazard ratio (HR) 0.72, 95% CI, 0.45–1.14, p = 0.155). Bleeding rate was lower for people without dementia (HR 0.56, 95% CI, 0.37–0.85). Adverse warfarin events were more common for residents of long-term care with dementia (adjusted incidence rate ratio 1.48, 95% CI, 1.20–1.82). Community-dwelling people with dementia treated with warfarin had poorer anticoagulation control than those without dementia (mean time in therapeutic range (TTR) % ±SD, 38±26 (dementia), 61±27 (no dementia), p < 0.0001). Conclusion: A lower proportion of people with dementia received oral anticoagulation compared with people without dementia. People with dementia had higher bleeding risk and poorer anticoagulation control when treated with warfarin.
- 1 June 2017
- Published by Elsevier in Accident Analysis & Prevention
- Vol. 103, 1-9
Are older drivers’ on-road driving error rates related to functional performance and/or self-reported driving experiences?
- 1 June 2017
- Published by Elsevier in Accident Analysis & Prevention
- Vol. 103, 1-9
Are older drivers’ on-road driving error rates related to functional performance and/or self-reported driving experiences?